Metagenomi Therapeutics (MGX) Shares Issued (2024 - 2025)
Metagenomi Therapeutics (MGX) reported Shares Issued of $109000.0 for Q3 2025, up 122.15% year-over-year from $49065.0 in Q3 2024, and up 122.15% quarter-over-quarter from -$492000.0 in Q3 2024.
Metagenomi Therapeutics (MGX) Shares Issued (2024 - 2025) Analysis & Trends
Metagenomi Therapeutics (MGX) has 2 years of Shares Issued data on file, last reported at $109000.0 in Q3 2025.
- Shares Issued for Q3 2025 came in at $109000.0, up 122.15% year-over-year; the trailing twelve-month figure through Sep 2025 was $109000.0 (changed N/A YoY), and the FY2024 annual result was $84.0 million, changed N/A from the prior year.
- Shares Issued climbed to $109000.0 in Q3 2025 per MGX's latest filing, from -$492000.0 in the prior quarter.
- Over five years, Shares Issued peaked at $86.5 million in Q1 2024 and troughed at -$2.0 million in Q2 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 821,726.73 Bn | 821,726.69 Bn | - | - |
| 2 | Belite Bio | 57,768.00 Bn | 57,768.00 Bn | - | - |
| 3 | Quantum Biopharma | 16,655.88 Bn | 16,655.88 Bn | - | 5.40 Mn |
| 4 | Legend Biotech | 3,540.00 Bn | 3,539.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,526.26 Bn | 1,526.24 Bn | - | - |
| 6 | Akari Therapeutics | 1,520.09 Bn | 1,520.09 Bn | - | - |
| 7 | Psyence Biomedical | 223.87 Bn | 223.87 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.47 Bn | 107.23 Bn | 2.59 Bn | 27.00 Mn |
| 9 | Abivax | 91.22 Bn | 91.22 Bn | - | 26,927.15 |
| 10 | Metagenomi Therapeutics | 42.84 Mn | 42.84 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 109,000.00 |
| Sep 30, 2025 | 109,000.00 |
| Sep 30, 2024 | -492,000.00 |
| Sep 30, 2024 | -492,000.00 |
| Jun 30, 2024 | -2.03 Mn |
| Jun 30, 2024 | -2.03 Mn |
| Mar 31, 2024 | 86.54 Mn |
| Mar 31, 2024 | 86.54 Mn |